A new crash test program from the Insurance Institute for Highway Safety aims to ensure that manufacturers pay attention to the safety of front passengers as well as drivers.
The test was developed after it became clear that some manufacturers were giving short shrift to the right side of the vehicle when it comes to small overlap front crash protection. A good or acceptable passenger-side rating will be required to qualify for the Institute’s 2018 TOP SAFETY PICK+ award.
The first test group in the passenger-side small overlap front test program did better overall than vehicles IIHS previously evaluated for research. Ten out of 13 midsize cars tested earn a good rating, while one is acceptable and two earn a marginal rating.
In contrast with a group of 2014-16 model small SUVs tested for research, none of the 2017-18 midsize cars had a poor or marginal structural rating. Instead, the biggest problem in the new group was inconsistent airbag protection in five cars, which would put passengers’ heads at risk.
I'm trying to think of something to say in behalf of this song but nothing come's to mind .... It was a really hard song to work on as with all of my other songs .... I had to save each new version of it on my external hard drive because I was working this song to the maximum capability of my musical program ... A couple of times, it froze up my computer and I wasn't able to save the changes ... I had to perform some extra research through forums on how to deal with the tech problems that I was faced with but in the end, I just took out my trusty hammer and I then had another conversation with my 2007 Intel quad-core computer about who run's this household and who is the boss and who is the bitch in this relationship ..... I first demonstrated my hammer on my coffee cup .... which I always hated the color of anyway .... and then with the most sinister glare that I could muster up, I then turned to my computer and said "If I don't have this song completed and on Youtube before the rise of the new moon .... you will be watching the rise of the new moon from outside .... all crammed up in the recycle bin while wearing this coffee cup on top of whatever is left of your circuitry .... You BUBBLY HEADED BOOBY !!!!! ...... Computers always heed to the voice of reason ..... The song is now done .... and I also now drink my coffee from a beer can.
As more than 2 million freshman head off to college, they enter one of the most dangerous times for harmful and underage student drinking—the first six weeks of their first year. And while there are numerous options available to address student drinking -- they are not all equally effective.
WHAT: The NIH’s National Institute on Alcohol Abuse and Alcoholism will hold a press briefing to announce the CollegeAIM (Alcohol Intervention Matrix) guide and website – the centerpiece of which is a new comprehensive and easy-to-use tool that will help inform decisions about alcohol interventions and guide college staff to science-based strategies.
Developed with input from leading alcohol researchers and college staff, CollegeAIM is distinctive because of the number and expertise of its contributors, the breadth of research covered by its analysis, and its user-friendly format.
To view the multimedia release go to:
http://www.multivu.com/players/English/7587851-niaaa-collegeaim-alcohol-intervention/
It’s a state capital, a center of Southern culture and the heart of the Research Triangle – and now, Raleigh, N.C., is also the setting for the HGTV® Smart Home 2016. Fans can visit HGTV.com/Smart to get a first look at the new home that, like its location, is a perfect blend of innovation and Carolina charm.
Constructed by locally owned builder, Homes by Dickerson, the home is part of a grand prize package valued at more than $1.2 million that will be awarded this summer. In addition to the home and all its furnishings, the grand prize package includes a 2016 Mercedes-Benz GLC and $100,000 from national mortgage lender Quicken Loans®. The three-level traditional craftsman home is approximately 3,300-square-feet, with four bedrooms and five bathrooms, cleverly constructed with tech gadgets and smart solutions to enhance entertaining and everyday living.
To view the multimedia release go to:
http://www.multivu.com/players/English/7780251-hgtv-smart-home-virtual-tour/
Don’t trust us, trust Science: Abbott is among the best science-based companies to work for in the world.
For the 13th consecutive year, the journal Science today recognized Abbott on its Top Employers list, evaluated on 23 characteristics including financial strength, easy adaptation to change and a having a research-driven environment.
”Abbott is unique in that we’ve been adding to our reservoir of scientific knowledge for 128 years,“ said John Frels, Ph.D., chair of Abbott’s Scientific Governing Board, which oversees the company’s senior scientific career track. ”We strive to bring in the best and brightest scientists and engineers to work on some of the biggest problems in healthcare today. This helps us to create new, breakthrough innovations that change people’s lives.“
To view the multimedia release go to:
http://www.multivu.com/players/English/7962251-science-names-abbott-2016-top-employer/
Make sure you do your research before
posting non-sensical comments! EMs a great rapper, but lacks example
and if you look deeper he is simply about money...at any cost! Women,
Kids, Family, Friends...all targets! He preys on the weak and wants no
part of a true solidier! And for the record this is hardly a
diss.
The American Association for Cancer Research (AACR) today released its annual Cancer Progress Report highlighting how federally funded research discoveries are fueling the development of new and even more effective ways to prevent, detect, diagnose, and treat cancer.
To view the multimedia release go to:
https://www.multivu.com/players/English/8385551-aacr-cancer-progress-report-2018/
Kiehl’s Since 1851, the 166-year-old skincare company, has used its fleet of iconic motorcycles to raise funds and awareness for AIDS research and awareness for the eighth year in a row. Kiehl’s LifeRide for amfAR, a charitable motorcycle ride from Minneapolis to Nashville, July 31 to Aug. 7, has already raised more than $125,000 for amfAR, The Foundation for AIDS Research and fundraising will continue through August.
Kiehl’s President Chris Salgardo and amfAR CEO Kevin Robert Frost led the 1,200 mile, 8-day journey, accompanied by actors Tyler Posey, Gilles Marini and Ian Bohen, tattoo artist Luke Wessman, and TV hosts Anthony Carrino and Grant Reynolds. Over eight days, the riders participated in nine public events, meeting customers and educating about HIV/AIDS research.
To view the multimedia release go to:
https://www.multivu.com/players/English/8160451-kiehls-liferide-for-amfar-aids-research-liferide8/
New Orleans is one of the country’s most culturally, architecturally, and musically interesting cities. It will serve as the picturesque backdrop for Team Challenge, the Crohn’s & Colitis Foundation of America’s (CCFA) endurance training and fundraising program, to take over the city on February 28, 2016 for the Rock ‘n’ Roll New Orleans Marathon, Half Marathon & 10k.
For the first time ever, Team Challenge is recruiting for participants to run through the Big Easy while raising critical funds and awareness of Crohn’s disease and ulcerative colitis. Collectively known as inflammatory bowel diseases (IBD), Crohn’s disease and ulcerative colitis are painful, medically incurable diseases that attack the digestive system. There are more than 1.6 million Americans living with these chronic, debilitating diseases.
“Team Challenge provides people with an opportunity to raise critical research dollars while training to do something that, for many people, they never imagined they’d be able to do,” said Craig Comins, vice president of Team Challenge. “It is inspiring to see a group of people come together, some who have these diseases and some who do not, united in the mission of finding a cure for Crohn’s disease and ulcerative colitis.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7512652-ccfa-team-challenge-recruit-nola/
Dentro de las más de 50 propuestas de estudios de investigación, el estudio sobre ácidos grasos de omega 3 en pacientes hospitalizados que requieren nutrición parenteral y presentan complicaciones relacionadas con insuficiencias intestinales propuesto por la investigadora médica, la Dra. Aurora Serralde Zúñiga, ganó el primer subsidio para la investigación sobre nutrición parenteral en América Latina (Parenteral Nutrition Research Grant Latin America).
To view the multimedia release go to:
https://www.multivu.com/players/Spanish/8451051-ganadora-del-subsidio-fresenius-kabi/
Announced today by VICHY Laboratoires, the VICHY EXPOSOME GRANT will promote and encourage research activity on the skin exposome. One research grant of 15 000 € will be awarded annually to a research project proposal in the field of exposome and skin.
What is exposome?
The human body is subjected to and responds to complex exposures throughout the lifespan, including exposures from the environment, diet, lifestyle. For this highly complex interaction, the term exposome was recently coined by Dr. Christopher Wild at the World Health Organization‘s International Agency for Research on Cancer.
The exposome analysis, therefore, complements the human genome by providing a comprehensive description of individuals’ lifelong environmental exposures. Exposome research aims to look at the holistic view of the human body’s exposures, how the body responds to those exposures, and their combined effects.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7751451-vichy-announces-exposome-grant/
Federally funded research continues to spur progress against cancer; however, accelerating the pace of progress will require robust, sustained, and predictable annual funding increases for the National Institutes of Health (NIH), the National Cancer Institute (NCI), and the Food and Drug Administration (FDA). Additionally, strong financial support for the National Cancer Moonshot Initiative is required, according to the sixth annual American Association for Cancer Research (AACR) Cancer Progress Report, released today.
One of the most exciting new approaches to cancer treatment is cancer immunotherapy. As detailed in the report, the utility of immunotherapy is expanding rapidly. For example, on Aug. 1, 2015, one class of immunotherapeutics, checkpoint inhibitors, was initially approved for just two types of cancer—melanoma and lung cancer. As of Sept. 1, 2016, checkpoint inhibitors have been approved for treating six types of cancer—bladder cancer, head and neck cancer, Hodgkin lymphoma, kidney cancer, lung cancer, and melanoma.
To view the multimedia release go to:
http://www.multivu.com/players/English/7911951-aacr-2016-cancer-progress-report/
